0001562180-20-006518.txt : 20201103 0001562180-20-006518.hdr.sgml : 20201103 20201103160509 ACCESSION NUMBER: 0001562180-20-006518 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20201029 FILED AS OF DATE: 20201103 DATE AS OF CHANGE: 20201103 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: HRUSOVSKY E KEVIN CENTRAL INDEX KEY: 0001252546 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38319 FILM NUMBER: 201283503 MAIL ADDRESS: STREET 1: 68 ELM STREET CITY: HOPKINTON STATE: MA ZIP: 01748 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Quanterix Corp CENTRAL INDEX KEY: 0001503274 STANDARD INDUSTRIAL CLASSIFICATION: LABORATORY ANALYTICAL INSTRUMENTS [3826] IRS NUMBER: 208957988 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 900 MIDDLESEX TURNPIKE CITY: BILLERICA STATE: MA ZIP: 01821 BUSINESS PHONE: 617-301-9400 MAIL ADDRESS: STREET 1: 900 MIDDLESEX TURNPIKE CITY: BILLERICA STATE: MA ZIP: 01821 4 1 primarydocument.xml PRIMARY DOCUMENT X0306 4 2020-10-29 false 0001503274 Quanterix Corp QTRX 0001252546 HRUSOVSKY E KEVIN C/O QUANTERIX CORPORATION, 900 MIDDLESEX TURNPIKE BILLERICA MA 01821 true true false false Chairman, President & CEO Common Stock 2020-10-29 4 S false 2000.00 38.30 D 1031798.00 D Common Stock 2020-11-02 4 S false 3264.00 36.9687 D 1028534.00 D The sales of shares was effected pursuant to a 10b5-1 trading plan adopted on December 5, 2019. Includes 156,763 restricted stock units and 39,815 shares of common stock that are subject to performance based vesting. The sales of shares reported on this Form 4 were made solely to cover tax obligations upon the vesting of 7,123 RSUs. This transaction was executed in multiple trades at prices ranging from $36.52 to $37.33. The price reported reflects the weighted average sale price. The reporting person undertakes to provide upon request to the SEC staff, the issuer or any security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Includes 149,640 restricted stock units and 39,815 shares of common stock that are subject to performance based vesting. /s/ Brian Keane, as Attorney-in-Fact 2020-11-03